Adenovirus pneumonia presenting with nodular shadows on chest X-ray in two unrelated allogeneic bone marrow transplant recipients

Internal Medicine

Volumn 53, Issue 5, 2014, Pages 499-503

  Mochizuki, Kanako ^a   Kondo, Yukio ^a   Hosokawa, Kohei ^a   Ohata, Kinya ^a   Yamazaki, Hirohito ^a   Takami, Akiyoshi ^a   Sasaki, Motoko ^a   Sato, Yasunori ^a   Nakanuma, Yasuni ^a   Nakao, Shinji ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Adenovirus; Allogeneic stem cell transplantation; Disseminated infection; Nodular shadows; Pneumonia

Indexed keywords

BILIRUBIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IMMUNOGLOBULIN A; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADENOVIRUS INFECTION; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER DYSFUNCTION; LUNG NODULE; MALE; MICROSCOPY; MIDDLE AGED; RESPIRATORY FAILURE; RISK FACTOR; THORAX RADIOGRAPHY; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; VIRUS PNEUMONIA; ADENOVIRIDAE; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; FATALITY; GRAFT RECIPIENT; PNEUMONIA; PROCEDURES; RADIOGRAPHY; VIROLOGY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADULT; BONE MARROW TRANSPLANTATION; FATAL OUTCOME; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PNEUMONIA, VIRAL; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED; TRANSPLANT RECIPIENTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84895081327     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.1192     Document Type: Article

References (28)

1. Ison MG. Adenovirus infections in transplant recipients. Clin Infect Dis 43: 331-339, 2006.
2. Neofytos D, Ojha A, Mookerjee B, et al. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant 13: 74-81, 2007.
3. Baldwin A, Kingman H, Darville M, et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant 26: 1333-1338, 2000.
4. Muller WJ, Levin MJ, Shin YK, et al. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis 41: 1812-1816, 2005.
5. Myers GD, Krance RA, Weiss H, et al. Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplant 36: 1001-1008, 2005.
6. Chakrabarti S, Mautner V, Osman H, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 100: 1619-1627, 2002.
7. Flomenberg P, Babbitt J, Drobyski WR, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 169: 775-781, 1994.
8. Runde V, Ross S, Trenschel R, et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 28: 51-57, 2001.
9. Munoz FM, Piedra PA, Demmler GJ. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis 27: 1194-1200, 1998.
10. Chakrabarti S, Donald WM, Moss PAH, et al. Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management. Leuk Lymphoma 45: 873-885, 2004.
11. Lion T, Baumgartinger R, Watzinger F, et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102: 1114-1120, 2003.
12. Wingard JR, Hiemenz JW, Jantz MA. How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation. Blood 120: 1791-1800, 2012.
13. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 157: 611-614, 1985.
14. Cassano WF. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 7: 247-248, 1991.
15. Murphy GF, Wood DP Jr, McRoberts JW, et al. Adenovirusassociated hemorrhagic cystitis treated with intravenous ribavirin. J Urol 149: 565-566, 1993.
16. Jurado M, Navarro JM, Hernández J, et al. Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin. Bone Marrow Transplant 15: 651-652, 1995.
17. Miyamura K, Hamaguchi M, Taji H, et al. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant 25: 545-548, 2000.
18. Hoffman JA, Shah AJ, Ross LA, et al. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7: 388-394, 2001.
19. Bhadri VA, Lee-Horn L, Shaw PJ. Safety and tolerability of cidofovir in high-risk pediatric patients. Transpl Infect Dis 11: 373-379, 2009.
20. Ljungman P, Ribaud P, Eyrich M, et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 31: 481-486, 2003.
21. Anderson EJ, Guzman-Cottrill JA, Kletzel M, et al. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. Pediatr Transplant 12: 219-227, 2008.
22. Yusuf U, Hale GA, Carr J, et al. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 81: 1398-1404, 2006.
23. Nagafuji K, Aoki K, Henzan H, et al. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 34: 909-914, 2004.
24. Platzbecker U, Bandt D, Thiede C, et al. Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation. Transplantation 71: 880-885, 2001.
25. Heemskerk B, Lankester AC, van Vreeswijk T, et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J Infect Dis 191: 520-530, 2005.
26. Kalpoe JS, van der Heiden PLJ, Barge RMY, et al. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning. Eur J Haematol 78: 314-321, 2007.
27. Feuchtinger T, Matthes-Martin S, Richard C, et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 134: 64-76, 2006.
28. Leen AM, Christin A, Myers GD, et al. Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood 114: 4283-4292, 2009.